BLA filing, board member, chief medical officer, clinical development plan, Clinical Trials, company and clinical strategy, in-licensing, IND filing, KOL management, medical affairs, NDA filing, phase I, phase II, phase III, phase IV, Preclinical studies, protocols, publishing, regulatory filing, Toxicology studies